1. Prologue to Transdermal Patch
1.1 Overview of Transdermal Patch
1.2 Relevance of Transdermal Patch


2. Types of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch


3. Mechanism of Transdermal Patch Drug Delivery
3.1 Properties of Transdermal Therapeutics
3.2 Components of Transdermal Patch
3.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods


4. Global Transdermal Patch Market Insight
4.1 Global Market Scenario
4.2 Regional Market Trends
4.2.1 United States
4.2.2 Europe
4.2.3 Asia Pacific


5. Transdermal Patches for Cardiovascular Diseases - Availability, Dosage & Price Analysis
5.1 Clonidine Transdermal Patch (Catapres–TTS)
5.2 Nitro Glycerin Transdermal Patch

6. Opioid Drug Containing Transdermal Patches - Availability, Dosage & Price Analysis
6.1 Fentanyl Transdermal Patch (Duragesic)
6.2 Buprenorphine Transdermal Patch (Butrans Patch)


7. Transdermal Patches for Neurological Disorders - Availability, Dosage & Price Analysis
7.1 Selegiline Transdermal Patch (Emsam)
7.2 Scopolamine Transdermal Patch (Transderm-Scop)
7.3 Rivastigmine Transdermal Patch (Exelon)
7.4 Methylphenidate Transdermal Patch (Daytrana)


8. Transdermal Patch in Hormonal Therapy - Availability, Dosage & Price Analysis
8.1 Estradiol Transdermal Patch
8.1.1 Alora
8.1.2 Vivelle-Dot
8.2 Testosterone Transdermal Patch (Androderm)
8.3 Ethinyl Estradiol & Norelgestromin Transdermal Patch (Xulane)


9. Transdermal Patches for Other Conditions - Availability, Dosage & Price Analysis
9.1 Nicotine Transdermal Patch (Nicoderm CQ)
9.2 Oxybutynin Transdermal Patch (Oxytrol)


10. Global Transdermal Patch Clinical Pipeline Overview
10.1 By Phase
10.2 By Region/Country
10.3 By Drug Class/Molecule
10.4 By Company
10.5 By Orphan & Fast Track Status
10.6 By Mode of Action


11. Global Patch Clinical Pipeline By Company, Indication & Phase
11.1 Unknown
11.2 Research
11.3 Preclinical
11.4 Clinical
11.5 Phase-I
11.6 Phase-I/II
11.7 Phase-II
11.8 Phase-III
11.9 Preregistration
11.10 Registered


12. Marketed Transdermal Patch Clinical Insight


13. Global Transdermal Patch Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges


14. Global Transdermal Patch Market Future Outlook 2026


15. Competitive Landscape
15.1 3M Pharmaceuticals
15.2 Acrux
15.3 Agile Therapeutics
15.4 Allergan
15.5 ANI Pharmaceuticals
15.6 Antares Pharma
15.7 Bayer HealthCare Pharmaceuticals
15.8 Corium International
15.9 Chase Pharmaceuticals
15.10 DURECT Corporation
15.11 Endo Pharmaceuticals
15.12 Fempharm
15.13 Hisamitsu Pharmaceutical
15.14 Immune Pharmaceuticals
15.15 Imprimis Pharmaceuticals
15.16 Ipsen Bioscience
15.17 Johnson & Johnson
15.18 LaSalle Laboratories
15.19 Lavipharm-increase
15.20 MINRAD International
15.21 NeurogesX
15.22 Noven Pharmaceuticals
15.23 NuPathe
15.24 Nuvo Research
15.25 Novartis
15.26 Pain Therapeutics
15.27 ProStrakan
15.28 Purdue Pharma
15.29 Sanofi
15.30 Scilex Pharmaceuticals
15.31 Senju Pharmaceutical
15.32 Somerset Pharmaceuticals
15.33 Teikoku Seiyaku
15.34 Therapeutic Discovery Corporation
15.35 Transdermal Delivery Solutions Corp
15.36 UCB
15.37 Xel Pharmaceuticals
15.38 Zosano Pharma